UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation

Wald, 1988, Maternal serum screening for Down's syndrome in early pregnancy, BMJ, 297, 883, 10.1136/bmj.297.6653.883

Nicolaides, 1992, Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy, BMJ, 304, 867, 10.1136/bmj.304.6831.867

Ville, 1992, First-trimester diagnosis of nuchal anomalies: significance and fetal outcome, Ultrasound Obstet Gynecol, 2, 314, 10.1046/j.1469-0705.1992.02050314.x

Szabo, 1995, First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age, Ultrasound Obstet Gynecol, 5, 161, 10.1046/j.1469-0705.1995.05030161.x

Taipale, 1997, Increased nuchal translucency as a marker for fetal chromosomal defects, N Engl J Med, 337, 1654, 10.1056/NEJM199712043372303

Snijders, 1996, First-trimester ultrasound screening for chromosomal defects, Ultrasound Obstet Gynecol, 7, 216, 10.1046/j.1469-0705.1996.07030216.x

Pandya, 1995, Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation, Br J Obstet Gynaecol, 102, 957, 10.1111/j.1471-0528.1995.tb10902.x

Snijders, 1995, Maternal age and gestational age specific risk for chromosomal defects, Fetal Diagn Ther, 10, 356, 10.1159/000264259

Nicolaides, 1994, Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy, Br J Obstet Gynaecol, 101, 782, 10.1111/j.1471-0528.1994.tb11946.x

Hecht, 1994, The imprecision in rates of Down syndrome by 1-year matenal age intervals: a critical analysis of rates used in biochemical screening, Prenat Diagn, 14, 729, 10.1002/pd.1970140814

1997, Recommendations of the 32nd Study Group of the Royal College of Obstetricians and Gynaecologists, 353

Pandya, 1995, Chromosomal defects and outcome in 1,015 fetuses with increased nuchal translucency, Ultrasound Obstet Gynecol, 5, 15, 10.1046/j.1469-0705.1995.05010015.x

Hyett, 1997, Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses, Am J Med Genet, 69, 207, 10.1002/(SICI)1096-8628(19970317)69:2<207::AID-AJMG18>3.0.CO;2-P

Hyett, 1997, Increased nuchal translucency at 10–14 weeks of gestation as a marker for major cardiac defects, Ultrasound Obstet Gynecol, 10, 242, 10.1046/j.1469-0705.1997.10040242.x

Souka, 1997, Diagnosis of fetal abnormalities at the 10–14-week scan, Ultrasound Obstet Gynecol, 429, 10.1046/j.1469-0705.1997.10060429.x

Sepulveda, 1996, The lambda sign at 10–14 weeks as a predictor of chorionicity in twin pregnancies, Ultrasound Obstet Gynecol, 7, 421, 10.1046/j.1469-0705.1996.07060421.x

Sebire, 1996, Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation, Br J Obstet Gynaecol, 103, 999, 10.1111/j.1471-0528.1996.tb09550.x

Sebire, 1997, The hidden mortality of monochorionic twin pregnancies, Br J Obstet Gynecol, 104, 1203, 10.1111/j.1471-0528.1997.tb10948.x

Braithwaite, 1996, Assessment of fetal anatomy at 12 to 13 weeks of gestation by transabdominal and transvaginal sonography, Br J Obstet Gynaecol, 103, 82, 10.1111/j.1471-0528.1996.tb09520.x

Pandya, 1996, The prevalence of non-viable pregnancy at 10–13 weeks of gestation, Ultrasound Obst Gynecol, 7, 170, 10.1046/j.1469-0705.1996.07030170.x